Registered entities
Axial Biotherapeutics, Inc.
Reg. No. 464394856United States
Innovation
10 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,022 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 7 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 3 |
Social engagement
Social engagement: 4.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
12 investors on record; lead investors include One Ventures, UTokyo Innovation Platform, Longwood Fund, Seventure Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 83% |
| Other / undisclosed | 2 | 17% |
Recent activity
19 May 2026
Milestone
regulatory
7 Jan 2026
Event
J.P. Morgan Healthcare Conference
16 Dec 2025
Leadership hire
Independent Chair of our BoardOfDirectors